ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,121.20
0.00%
Dow Jones
39,331.85
0.41%
Gold vs US Dollar
2,333.405
0.14%
Brent Oil
86.475
0.03%
Bitcoin
61,059.93
-1.56%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Organicell Regenerative Medicine Inc (QB) (OCEL)

  7. Organicell Regenerative Medicine Inc (QB) (OCEL) News

Organicell Regenerative ... (QB) (OCEL)

Organicell Regenerative Medicine Inc (QB)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:OCEL
DateTimeSourceHeadlineSymbolCompany
27/11/202322:00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
14/11/202321:29Edgar (US Regulatory)Form 8-K - Current reportUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
19/10/202311:56Edgar (US Regulatory)Form PRER14C - Information statementsUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
28/09/202319:54Edgar (US Regulatory)Form PRE 14C - Other preliminary information statementsUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
14/09/202321:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
25/08/202320:13Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
14/08/202321:34Edgar (US Regulatory)Form DEF 14C - Other definitive information statementsUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
09/08/202321:05Edgar (US Regulatory)Form 8-K - Current reportUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
01/08/202321:15Edgar (US Regulatory)Form PRE 14C - Other preliminary information statementsUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
26/07/202314:00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
11/07/202322:00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
11/07/202321:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
30/06/202321:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
30/06/202321:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
29/06/202314:01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
29/06/202314:00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
28/06/202321:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
28/06/202321:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
21/06/202313:46Edgar (US Regulatory)Current Report Filing (8-k)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
16/06/202321:07Edgar (US Regulatory)Quarterly Report (10-q)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
14/06/202321:02Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
09/06/202321:36Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
09/06/202321:06Edgar (US Regulatory)Current Report Filing (8-k)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
15/05/202321:10Edgar (US Regulatory)Current Report Filing (8-k)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
01/05/202321:06Edgar (US Regulatory)Current Report Filing (8-k)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
21/04/202321:06Edgar (US Regulatory)Current Report Filing (8-k)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
17/03/202320:17Edgar (US Regulatory)Quarterly Report (10-q)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
08/03/202321:06Edgar (US Regulatory)Current Report Filing (8-k)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
14/02/202321:59Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
14/02/202321:39Edgar (US Regulatory)Annual Report (10-k)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
 Showing the most relevant articles for your search:USOTC:OCEL

Your Recent History

LSE
GKP
Gulf Keystone Petroleum
LSE
ALTN
Altyngold
LSE
AAZ
Anglo Asian Mining
LSE
MNL
Manchester & London Inve...
LSE
PFC
Petrofac
LSE
ENET
Ethernity Networks
LSE
ARS
Asiamet Resources
LSE
ALBA
Alba Mineral Resources
LSE
DEC
Diversified Energy
LSE
MIN
Minoan
LSE
JSE
Jadestone Energy
LSE
BOO
Boohoo
LSE
SVML
Sovereign Metals
LSE
EDEN
Eden Research
NASDAQ
SLN
Silence Therapeutics
LSE
VAST
Vast Resources
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved